Anemia, Hemorrhage, and Transfusion in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 104, Issue 5 SUPPL., 2009, Pages 34C-38C

  Willis, Patrick ^a   Voeltz, Michele Doughty ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; HIRULOG; PLACEBO; PRASUGREL;

ACUTE CORONARY SYNDROME; ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; STENT THROMBOSIS; TISSUE OXYGENATION; UNSTABLE ANGINA PECTORIS;

EID: 68749096118     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.013     Document Type: Article

References (23)

1. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
2. Boersma E., Akkerhuis K.M., Theroux P., Califf R.M., Topol E.J., and Simoons M.L. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 100 (1999) 2045-2048
3. Nikolsky E., Mehran R., Aymong E.D., Mintz G.S., Lansky A.J., Lasic Z., Negoita M., Fahy M., Pocock S.J., Na Y., et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 1023-1027
4. Moscucci M., Fox K.A., Cannon C.P., Klein W., Lopez-Sendon J., Montalescot G., White K., and Goldberg R.J. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
5. Hebert P.C., Yetisir E., Martin C., Blajchman M.A., Wells G., Marshall J., Tweeddale M., Pagliarello G., and Schweitzer I. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 29 (2001) 227-234
6. McKechnie R.S., Smith D., Montoye C., Kline-Rogers E., O'Donnell M.J., DeFranco A.C., Meengs W.L., McNamara R., McGinnity J.G., Patel K., et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110 (2004) 271-277
7. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
8. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
9. Voeltz M.D., Patel A.D., Feit F., Fazel R., Lincoff A.M., and Manoukian S.V. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 99 (2007) 1513-1517
10. Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003) 853-863
11. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
12. Breddin K., Loew D., Lechner K., Oberla K., and Walter E.o.b.o.t.G.-A.S.Group. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. Circulation 62 (1980) V63-V72
13. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247 (1982) 1707-1714
14. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
15. Manoukian S.V., Feit F., Mehran R., Voeltz M.D., Ebrahimi R., Hamon M., Dangas G.D., Lincoff A.M., White H.D., Moses J.W., et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49 (2007) 1362-1368
16. Stone G.W., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., Kornowski R., Hartmann F., Gersh B.J., Pocock S.J., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
17. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
18. Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., Neumann F.J., Ardissino D., De Servi S., Murphy S.A., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007) 2001-2015
19. Perrotta P.L., and Snyder E.L. Non-infectious complications of transfusion therapy. Blood Rev 15 (2001) 69-83
20. Fransen E., Maessen J., Dentener M., Senden N., and Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116 (1999) 1233-1239
21. Rao S.V., Jollis J.G., Harrington R.A., Granger C.B., Newby L.K., Armstrong P.W., Moliterno D.J., Lindblad L., Pieper K., Topol E.J., Stamler J.S., and Califf R.M. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
22. Fortune J.B., Feustel P.J., Saifi J., Stratton H.H., Newell J.C., and Shah D.M. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Trauma 27 (1987) 243-249
23. Marik P.E., and Sibbald W.J. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269 (1993) 3024-3029